Selected Recent Posters
2022 December - American Association for Cancer Research and the Japanese Cancer Association joint meeting; "ERBB4 Drives BRAF-WT Melanoma"; Poster
2022 October - University of Alabama-Birmingham O'Neal Comprehensive Cancer Center Retreat; "ERBB4 is a Driver of BRAF-WT Melanoma"; PosterÂ
2022 April - Auburn University BMES Showcase; "ERBB4 is a Driver of BRAF-WT Melanoma"; Poster
2022 April - AACR Annual Meeting (New Orleans, LA); "ERBB4 is a Driver of BRAF-WT Melanoma"; Poster
2021 July - AACR Annual Meeting (virtual); "Identification of ERBB4 mutant alleles that function as tumor drivers"; Abstract; Poster
2020 October - EORTC-NCI-AACR Meeting (virtual); "Targeting BRAF WT metastatic melanomas: Identifying ERBB4 mutant alleles as biomarkers and targets for novel combinatorial treatment strategies"; Poster; Audio narration
2020 October - AAPS Annual Meeting (virtual); "Targeting BRAF WT metastatic melanomas: Identifying ERBB4 mutant alleles as biomarkers and targets for novel combinatorial treatment strategies"; Poster; Audio narration
2020 June - AACR Annual Meeting (virtual); "Targeting BRAF WT metastatic melanomas: Identifying ERBB4 mutant alleles as biomarkers and targets for novel combinatorial treatment strategies"; Poster; Audio narration
2019 March - AACR Annual Meeting (Atlanta, GA); "In metastatic melanoma, mutations in ERBB4 may interact with mutations affecting the RAS/RAF/MEK/MAPK pathway"; Poster
2019 January - AACR Melanoma Meeting (Houston, TX); "Characterization of selective and non-selective inhibitors of ERBB4 signaling: Putative targeted melanoma therapeutics"; Poster
2019 January - AACR Melanoma Meeting (Houston, TX); "Mutations in ERBB4 may account for clinical resistance of melanomas to inhibitors of the RAS/RAF/MEK/MAPK pathway"; Poster